Serum interleukin-6 in relation to acute-phase reactants and survival in patients with renal cell carcinoma

European Journal of Cancer

Volumn 33, Issue 11, 1997, Pages 1794-1798

  Ljungberg, B ^a,b   Grankvist, K ^a   Rasmuson, T ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b NONE

Author keywords

CRP; Erythrocyte sedimentation rate; Interleukin 6; Prognosis; Renal cell carcinoma; Tumour stage

Indexed keywords

INTERLEUKIN 6;

ACUTE PHASE RESPONSE; ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS;

ACUTE-PHASE REACTION; ADULT; AGED; AGED, 80 AND OVER; BLOOD SEDIMENTATION; CARCINOMA, RENAL CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERLEUKIN-6; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM PROTEINS; PROGNOSIS; SURVIVAL RATE;

EID: 0031415831     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00179-2     Document Type: Article

References (24)

1. Robson CJ, Churchill BM, Anderson W. The results of radical nephrectomy for renal cell carcinoma. J Urol 1969, 101, 297-301.
2. Skinner DG, Colvin RB, Vermillion CD, Pfister RC, Leadbetter WF. Diagnosis and management of renal cell carcinoma. A clinical and pathological study of 309 cases. Cancer 1971, 28, 1165-1177.
3. Taneja SS, Pierce W, Figlin R, Belldegrun A. Management of disseminated kidney cancer. Urol Clin North Am 1994, 21, 625-637.
4. Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochem J 1990, 265, 621-636.
5. Baumann H, Gauldie J. The acute phase response. Immunol Today 1994, 15, 74-80.
6. Luger TA, Krutmann J, Kirnbauer R, et al. IFNβ2/IL-6 augments the activity of human natural killer cells. J Immunol 1989, 143, 1206-1209.
7. Takai Y, Wong GG, Clark SC, Burakoff SJ, Herrmann SH. B cell stimulatory factor 2 is involved in the in vitro induction of cytotoxic T lymphocytes. J Immunol 1988, 140, 508-514.
8. Castell JV, Gómez-Lechón MJ, David M, Hirano T, Kishimoto T, Heinrich PC. Acute phase response of human hepatocytes; regulation of acute phase synthesis by IL-6. Hepatology 1990, 12, 1179-1186.
9. Blay J-Y, Negrier S, Combaret V, et al. Serum level of interleukin 6 as prognosis factor in metastatic renal cell carcinoma. Cancer Res 1992, 52, 3317-3322.
10. Dosquet C, Schaetz A, Faucher C, et al. Tumour necrosis factor-α, interleukin-1β and interleukin-6 in patients with renal cell carcinoma. Eur J Cancer 1994, 30A, 162-167.
11. Gogusev J, Augusti M, Chrétien Y, Droz D. Interleukin-6 and TNF-α production in human renal cell carcinoma. Kidney Int 1993, 44, 585-592.
12. Hermanek P, Sobin LJ, eds. UICC, TNM classification of malignant tumours, 4th edn, 2nd revision. Berlin, Springer-Verlag, 1992.
13. Sothern RB, Roitman-Johnson B, Kanabrocki EL, et al. Circadian characteristics of circulating interleukin-6 in men. J Allergy Clin Immunol 1995, 95, 1029-1035.
14. Seymour JF, Talpaz M, Cabanillas F, Wetzler M, Kurzrock R. Serum interleukin-6 levels correlate with prognosis in diffuse large-cell lymphoma. J Clin Oncol 1995, 13, 575-582.
15. Scambia G, Testa U, Benedetti P, et al. Prognostic significance of interleukin 6 serum levels in patients with ovarian cancer. Br J Cancer 1995, 71, 354-356.
16. Yanagawa H, Sone S, Takahasi Y, et al. Serum levels of interleukin 6 in patients with lung cancer. Br J Cancer 1995, 71, 1095-1098.
17. Miki S, Iwano M, Miki Y, et al. IL-6 functions as an autocrine growth factor in renal carcinomas. FEBS Lett 1989, 250, 607-610.
18. Takenawa J, Kanako Y, Fukyumoto M, et al. Enhanced expression of IL-6 in primary human renal cell carcinoma. J Natl Cancer Inst 1991, 83, 1668-1672.
19. Koo AS, Armstrong C, Bochner B, et al. Interleukin-6 and renal cell cancer: production, regulation and growth effects. Cancer Immunol Immunother 1992, 35, 97-105.
20. Blay J-Y, Schemann S, Favrot MC. Local production of interleukin 6 by renal adenocarcinoma in vivo. J Natl Cancer Inst 1994, 86, 238.
21. Wu S, Rodabaugh K, Martinez-Maza O, et al. Stimulation of ovarian tumour cell proliferation with monocytes products including interleukin-1, interleukin-6 and tumor necrosis factor-A. Am J Obstet Gynecol 1992, 166, 997-1007.
22. Tamm I, Cardinale I, Kreuger J, Murphy JS, May LT, Seghall PB. Interleukin-6 decreases cell-cell association and increases mobility of ductal breast carcinoma cells. J Exp Med 1989, 170, 1649-1669.
23. Ljungberg B, Grankvist K, Rasmuson T. Serum acute phase reactants and prognosis in renal cell carcinoma. Cancer 1995, 76, 1435-1439.
24. Tsukamoto T, Kumamoto Y, Miyao N, Masumori N, Takahashi A, Yanase M. Interleukin-6 in renal cell carcinoma. J Urol 1992, 148, 1778-1782.